help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quintanilla-Martinez, L.
Right arrow Articles by Raffeld, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quintanilla-Martinez, L.
Right arrow Articles by Raffeld, M.
(American Journal of Pathology. 1998;153:175-182.)
© 1998 American Society for Investigative Pathology

Regular Articles

Mantle Cell Lymphomas Lack Expression of p27kip1, a Cyclin-Dependent Kinase Inhibitor

Leticia Quintanilla-Martinez* , Catherine Thieblemont* , Falko Fend* , Shimareet Kumar* , Magda Pinyol{dagger} , Elias Campo{dagger} , Elaine S. Jaffe* and Mark Raffeld*

From the Hematopathology Section, Laboratory of Pathology,* National Cancer Institute, National Institutes of Health, Bethesda, Maryland, and the Hospital Clinic Provincial,{dagger} University of Barcelona, Barcelona, Spain

p27Kip1 is a cyclin-dependent kinase inhibitor that regulates the decision to enter S phase or withdraw from the cell cycle. In resting cells, the level of p27Kip1 provides an inhibitory threshold above which G1 cyclin D/E/cyclin-dependent kinases accumulate before activation; however, in cycling cells, p27Kip1 protein is sequestered by high levels of active cyclin D/cyclin-dependent kinase 4 complexes. As a group, the cyclin-dependent kinase inhibitors have been proposed to act as tumor suppressor genes, and several members have been implicated in the pathogenesis of a variety of human cancers. We examined p27Kip1 expression in 116 non-Hodgkin's lymphomas including 50 cases of MCL (40 typical and 10 blastic variants), 21 follicular lymphomas, 20 diffuse large B-cell lymphomas, 16 chronic lymphocytic leukemias, 8 marginal zone B-cell lymphomas, and 1 splenic marginal zone lymphoma, and correlated its expression with that of the proliferation marker Ki67 (MiB1) and with p53. p27Kip1 gene structure was analyzed by Southern blot in the group of MCLs. In all cases of non-Hodgkin's lymphoma other than MCL, p27Kip1 expression was inversely related to the proliferation index as measured by Ki67. In contrast, in typical MCL, p27Kip1 expression was negative in 35 of 40 (88%) cases, irrespective of the proliferative rate (median 15%; range 2 to 90%). Paradoxically, in the blastic variant of MCL, 8 of 10 (80%) cases showed expression of p27Kip1, despite a high proliferation rate (median 60%; range 32 to 100%). However, the staining in most of the cases was less intense than in the reactive T lymphocytes. Deletions of p27Kip1 gene were not found in any of the 25 cases examined. p53 expression was found in 15 of 50 cases of MCL: 7 of 10 (70%) in the blastic variant and 8 of 40 (20%) in the typical MCL (70% vs. 20%, P < 0.0045). These results demonstrate that MCLs, in contrast to other non-Hodgkin's lymphomas and normal lymphoid tissue, fail to correlate p27Kip1 expression with the proliferation rate. This peculiar uncoupling of p27Kip1 protein expression from the proliferation rate may be related to the high levels of cyclin D1 expressed in MCL and is likely to have profound effects on cell cycle regulation and contribute to the pathogenesis of MCL.




This article has been cited by other articles:


Home page
 BloodHome page
M. Luqman, S. Klabunde, K. Lin, G. V. Georgakis, A. Cherukuri, J. Holash, C. Goldbeck, X. Xu, E. E. Kadel III, S. H. Lee, et al.
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
Blood, August 1, 2008; 112(3): 711 - 720.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. A. Tucker, A. I. Kapanen, G. Chikh, B. G. Hoffman, A. H. Kyle, I. M. Wilson, D. Masin, R. D. Gascoyne, M. Bally, and R. J. Klasa
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-{kappa}B, p53, bax, and p27 levels
Mol. Cancer Ther., April 1, 2008; 7(4): 749 - 758.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Fu, D. D. Weisenburger, T. C. Greiner, S. Dave, G. Wright, A. Rosenwald, M. Chiorazzi, J. Iqbal, S. Gesk, R. Siebert, et al.
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling
Blood, December 15, 2005; 106(13): 4315 - 4321.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Guidoboni, P. Zancai, R. Cariati, S. Rizzo, J. Dal Col, A. Pavan, A. Gloghini, M. Spina, A. Cuneo, F. Pomponi, et al.
Retinoic Acid Inhibits the Proliferative Response Induced by CD40 Activation and Interleukin-4 in Mantle Cell Lymphoma
Cancer Res., January 15, 2005; 65(2): 587 - 595.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
M. L. Taylor, D. Sehgal, M. Raffeld, H. Obiakor, C. Akin, R. G. Mage, and D. D. Metcalfe
Demonstration That Mast Cells, T Cells, and B Cells Bearing the Activating Kit Mutation D816V Occur in Clusters within the Marrow of Patients with Mastocytosis
J. Mol. Diagn., November 1, 2004; 6(4): 335 - 342.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. L. Feldman, S. K. Libutti, J. F. Pingpank, D. L. Bartlett, T. H. Beresnev, S. M. Mavroukakis, S. M. Steinberg, D. J. Liewehr, D. E. Kleiner, and H. R. Alexander
Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal Chemotherapy
J. Clin. Oncol., December 15, 2003; 21(24): 4560 - 4567.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Quintanilla-Martinez, M. Kremer, K. Specht, J. Calzada-Wack, M. Nathrath, R. Schaich, H. Hofler, and F. Fend
Analysis of Signal Transducer and Activator of Transcription 3 (Stat 3) Pathway in Multiple Myeloma: Stat 3 Activation and Cyclin D1 Dysregulation Are Mutually Exclusive Events
Am. J. Pathol., May 1, 2003; 162(5): 1449 - 1461.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Quintanilla-Martinez, T. Davies-Hill, F. Fend, J. Calzada-Wack, L. Sorbara, E. Campo, E. S. Jaffe, and M. Raffeld
Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis
Blood, April 15, 2003; 101(8): 3181 - 3187.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
V. Franco, A. M. Florena, and E. Iannitto
Splenic marginal zone lymphoma
Blood, April 1, 2003; 101(7): 2464 - 2472.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris
Cell cycle deregulation in B-cell lymphomas
Blood, February 15, 2003; 101(4): 1220 - 1235.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Decker, S. Hipp, I. Ringshausen, C. Bogner, M. Oelsner, F. Schneller, and C. Peschel
Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin
Blood, January 1, 2003; 101(1): 278 - 285.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. S. Lim, A. Adamson, Z. Lin, B. Perez-Ordonez, R. C. K. Jordan, S. Tripp, S. L. Perkins, and K. S. J. Elenitoba-Johnson
Expression of Skp2, a p27Kip1 ubiquitin ligase, in malignant lymphoma: correlation with p27Kip1 and proliferation index
Blood, September 26, 2002; 100(8): 2950 - 2956.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
L Leoncini, S Lazzi, C Bellan, and P Tosi
Cell kinetics and cell cycle regulation in lymphomas
J. Clin. Pathol., September 1, 2002; 55(9): 648 - 655.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Specht, M. Kremer, U. Muller, S. Dirnhofer, M. Rosemann, H. Hofler, L. Quintanilla-Martinez, and F. Fend
Identification of Cyclin D1 mRNA Overexpression in B-Cell Neoplasias by Real-Time Reverse Transcription-PCR of Microdissected Paraffin Sections
Clin. Cancer Res., September 1, 2002; 8(9): 2902 - 2911.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Gloghini, G. Gaidano, L. M. Larocca, F. Pierconti, A. Cingolani, L. Dal Maso, D. Capello, S. Franceschi, U. Tirelli, M. Libra, et al.
Expression of Cyclin-Dependent Kinase Inhibitor p27Kip1 in AIDS-Related Diffuse Large-Cell Lymphomas Is Associated with Epstein-Barr Virus-Encoded Latent Membrane Protein 1
Am. J. Pathol., July 1, 2002; 161(1): 163 - 171.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Chiarle, Y. Fan, R. Piva, H. Boggino, J. Skolnik, D. Novero, G. Palestro, C. De Wolf-Peeters, M. Chilosi, M. Pagano, et al.
S-Phase Kinase-Associated Protein 2 Expression in Non-Hodgkin's Lymphoma Inversely Correlates with p27 Expression and Defines Cells in S Phase
Am. J. Pathol., April 1, 2002; 160(4): 1457 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
B. Madewell, S. Griffey, J. Walls, and R. Gandour-Edwards
Reduced Expression of Cyclin-dependent Kinase Inhibitor p27Kip1 in Feline Lymphoma
Vet. Pathol., November 1, 2001; 38(6): 698 - 702.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. E. Straus, E. S. Jaffe, J. M. Puck, J. K. Dale, K. B. Elkon, A. Rosen-Wolff, A. M. J. Peters, M. C. Sneller, C. W. Hallahan, J. Wang, et al.
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis
Blood, July 1, 2001; 98(1): 194 - 200.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Carbone, A. Gloghini, D. Bontempo, P. Monini, U. Tirelli, R. Volpe, P. J. Browning, and G. Gaidano
Proliferation in HHV-8-Positive Primary Effusion Lymphomas Is Associated with Expression of HHV-8 Cyclin but Independent of p27kip1
Am. J. Pathol., April 1, 2000; 156(4): 1209 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Yatabe, R. Suzuki, K. Tobinai, Y. Matsuno, R. Ichinohasama, M. Okamoto, M. Yamaguchi, J.-i. Tamaru, N. Uike, Y. Hashimoto, et al.
Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma
Blood, April 1, 2000; 95(7): 2253 - 2261.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Chiarle, L. M. Budel, J. Skolnik, G. Frizzera, M. Chilosi, A. Corato, G. Pizzolo, J. Magidson, A. Montagnoli, M. Pagano, et al.
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma
Blood, January 15, 2000; 95(2): 619 - 626.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Sanchez-Beato, F. I. Camacho, J. C. Martinez-Montero, A. I. Saez, R. Villuendas, L. Sanchez-Verde, J. F. Garcia, and M. A. Piris
Anomalous High p27/KIP1 Expression in a Subset of Aggressive B-Cell Lymphomas Is Associated With Cyclin D3 Overexpression. p27/KIP1---Cyclin D3 Colocalization in Tumor Cells
Blood, July 15, 1999; 94(2): 765 - 772.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Fend, L. Quintanilla-Martinez, S. Kumar, M. W. Beaty, L. Blum, L. Sorbara, E. S. Jaffe, and M. Raffeld
Composite Low Grade B-Cell Lymphomas with Two Immunophenotypically Distinct Cell Populations Are True Biclonal Lymphomas : A Molecular Analysis Using Laser Capture Microdissection
Am. J. Pathol., June 1, 1999; 154(6): 1857 - 1866.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. V. Lloyd, L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer
p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers
Am. J. Pathol., February 1, 1999; 154(2): 313 - 323.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.